Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans

@inproceedings{Kimura2017PilotSC,
  title={Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans},
  author={Yukiko Kimura and S Cherukumilli Grevich and Timothy Beukelman and Esi M Morgan and Peter A Nigrovic and Kelly L. Mieszkalski and Thomas Brent Graham and Mar{\'i}a Florencia Ibarra and Norman T. Ilowite and Marisa S. Klein-Gitelman and Karen Brandt Onel and Sampath Prahalad and Marilynn G. Punaro and Sarah M Ringold and A Askanase and Heather A van Mater and Jennifer E. Weiss and Pamela F Weiss and Laura E. Schanberg},
  booktitle={Pediatric rheumatology online journal},
  year={2017}
}
ObjectivesTo assess the feasibility of studying the comparative effectiveness of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) consensus treatment plans (CTPs) for systemic Juvenile Idiopathic Arthritis (JIA) using an observational registry.MethodsUntreated systemic JIA patients enrolled in the CARRA Registry were begun on one of 4 CTPs chosen by the treating physician and patient/family (glucocorticoid [GC] alone; methotrexate [MTX] ± GC; IL1 inhibitor [IL1i] ± GC; IL6… CONTINUE READING
BETA
2
Twitter Mentions

References

Publications referenced by this paper.
SHOWING 1-10 OF 27 REFERENCES

Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis

F De Benedetti, HI Brunner, +7 authors P Woo
  • N Engl J Med
  • 2012

Similar Papers

Loading similar papers…